PER

4.65%

9.0¢ percheron therapeutics limited

Ann: Antisense Therapeutics CEO announces retirement, page-78

First 78 Last

Share
Profile

Follow
mephistophles

1,068 Posts.

499

16/11/22

22:46

Post #: 64819634
Share

Originally posted by BoomCrashOffera: ↑

I’d be okay with the scale of the PAB sign-on deal. PAB has 2.06 bill shares outstanding, conveniently three times ANP’s, so 8 million PAB options equates to 2.67 billion ANP share options, spread out over 3 years in 4 tranches of 667,000 options each year.

At PAB’s close of 1.9c and ANP’S close of 10c, the PAB strike at 4.5c equates to an ANP strike of 23.5c . Similarly 5c equates to 26.5c and 7c translates to an ANP strike of 37c. Not to mention that if 43% above the share price is higher than these prices at issuance, then that price becomes the strike.

At first half CY24 hypothetically, assuming the phase 2b trial is successful, CG would be entitled, in the PAB model translated to ANP, to exercise 1.33 million ANP shares at about 25c average strike. At a share price of say 60c at that stage, would be a bonus of about $465k and a share dilution to other ANP shareholders of 0.2%. Totally reasonable. PAB have the scale about right imho.

As Sam made the point, it’s not the options issuance, but the potential scale of Res 2’s option issuance. Assuming the 67 million are issued (why ask for them to be approved if you don’t intend to use them), that is 10% dilution to existing shareholders, and a potential windfall of $20-$30 mill for ESOP grantees with no risk of loss.

I find it contradictory from you that you say CG doesn’t need the money, but giving her a money incentive is good.

I agree it’s good, at the right scale.

Expand

> why ask for them to be approved if you don’t intend to use them

Um, in case a situation arises, wherein it's prudent to use them? Charmaine stated that they want to have the option to use them, to attract and retain talent.

Hmmmmm. Attract talent....

Perhaps the title of the thread you're responding to might hint at a potentially prudent use of some of those options:

Antisense Therapeutics CEO announces retirement.

I for one hope they use a decent chunk of them, procuring some serious talent.

Good luck!

ANP Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

3 Great analysis

Reply

Top Stories

ENV

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

VUL

Vulcan appoints investment bank and M&A veteran to board

MM8

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

MKG

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

MLS

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

AZY

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

There are more pages in this discussion • 127 more messages in this thread...

First 78 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 9.0¢		Change 0.004(4.65%)		Mkt cap ! $81.13M

Open	High	Low	Value	Volume
8.6¢	9.1¢	8.5¢	$181.6K	2.049M

Buyers (Bids)

No.	Vol.	Price($)
1	10344	8.7¢

Sellers (Offers)

Price($)	Vol.	No.
9.0¢	64275	1

View Market Depth

No.	Vol.	Price($)
1	100000	0.085
2	155000	0.084
1	150000	0.083
1	36585	0.082
3	43077	0.081

Price($)	Vol.	No.
0.090	64275	1
0.091	106821	1
0.092	50000	1
0.094	160000	1
0.095	550000	2

Last trade - 16.10pm 13/09/2024 (20 minute delay)

PER (ASX) Chart

Ann: Antisense Therapeutics CEO announces retirement, page-78

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Utah authorities sign off on Anson's lithium extraction plans at Green River

Vulcan appoints investment bank and M&A veteran to board

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Antisense Therapeutics CEO announces retirement, page-78

Top Stories

Enova Mining unveils "high-grade" REE drill hits at Coda North, Brazil

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Utah authorities sign off on Anson's lithium extraction plans at Green River

Vulcan appoints investment bank and M&A veteran to board

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Mako sniffs gold at 170 g/t at Cote d’Ivoire's Napié play

Metals Australia kicking off plant study at Lac Carheil; Canadian tariff tailwind potential

Antipa divests its Citadel interest to JV partner Rio for A$17M, refocuses on Minyari Dome

Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News